About Lengo Therapeutics
Lengo Therapeutics is a private company based in New York, New York, incorporated in 2023 in New York. It has reported $0 raised in one offering on Form D since April 2023. Its chief executive is Jia Sheng Loo.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Apr 11, 2023 | $0of $7.0M target | 0 | — | EquityRule 506(c) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lengo Therapeutics's Form D filed Apr 11, 2023.
JL
Jia Sheng Loo
CEO and director